Register

Please register so we can remember your preferences, like your favourite suppliers and preferred news & events.


Supplier Login



New user? Register as a supplier


Forgot password?


My Account

Aerie Pharmaceuticals appoints Barry Ivin as Site Director of new manufacturing plant in Ireland

Aerie Pharmaceuticals, a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, has appointed Barry Ivin as Site Director of Aerie’s new manufacturing plant in Athlone, Ireland.

Aerie Pharmaceuticals appoints Barry Ivin as Site Director of new manufacturing plant in Ireland

On 9 January 2017, Aerie entered into a lease agreement with Ireland’s Industrial Development Agency for the Athlone site.

Mr Ivin will be responsible for leadership and direction over the build-out and validation of the plant and, if Aerie receives regulatory approval, future manufacturing operations for commercial product supply.

He has significant site leadership and engineering experience, and was most recently employed by Genzyme Ireland Limited (Sanofi), Waterford.

Mr Ivin holds a Chemical Engineering undergraduate degree from University of South Wales and a Masters of Business Administration from the Graduate School of Business, University College Dublin.

Read More


Categories

Market News

Other news in “Market News”

Hikma announces new licensing agreement with Takeda for products in the MENA

Hikma announces new licensing agreement with Takeda for products in the MENA 

17 Aug 2017
Pfizer to adopt Orion cloud platform for computational chemistry

Pfizer to adopt Orion cloud platform for computational chemistry 

17 Aug 2017
Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector

Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector 

17 Aug 2017

Are you a supplier? Here's what we can do for you

Register now